Matches in Wikidata for { <http://www.wikidata.org/entity/Q67129299> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q67129299 description "clinical trial" @default.
- Q67129299 description "ensayu clínicu" @default.
- Q67129299 description "klinisch onderzoek" @default.
- Q67129299 description "клінічне випробування" @default.
- Q67129299 name "Healthcare Costs Among Patients With CML Receiving Dasatinib or Nilotinib in a Commercial and Medicare Population" @default.
- Q67129299 name "Healthcare Costs Among Patients With CML Receiving Dasatinib or Nilotinib in a Commercial and Medicare Population" @default.
- Q67129299 type Item @default.
- Q67129299 label "Healthcare Costs Among Patients With CML Receiving Dasatinib or Nilotinib in a Commercial and Medicare Population" @default.
- Q67129299 label "Healthcare Costs Among Patients With CML Receiving Dasatinib or Nilotinib in a Commercial and Medicare Population" @default.
- Q67129299 prefLabel "Healthcare Costs Among Patients With CML Receiving Dasatinib or Nilotinib in a Commercial and Medicare Population" @default.
- Q67129299 prefLabel "Healthcare Costs Among Patients With CML Receiving Dasatinib or Nilotinib in a Commercial and Medicare Population" @default.
- Q67129299 P1050 Q67129299-ACBC8393-D3CD-4795-AF22-48C54D5586F2 @default.
- Q67129299 P1132 Q67129299-B2D4DAAA-7A7F-4B35-B435-37CEEF8A84B7 @default.
- Q67129299 P1476 Q67129299-B97905D5-87AD-4D2F-B4E6-79FB2E9872FD @default.
- Q67129299 P17 Q67129299-14D181E4-078C-48ED-B34A-929AD316D5B9 @default.
- Q67129299 P2899 Q67129299-3E14B872-53FB-4EEF-9617-9937DCA767B0 @default.
- Q67129299 P3098 Q67129299-03F5354A-6165-457F-BE33-3DF51D9627F9 @default.
- Q67129299 P31 Q67129299-3841C90A-B1B6-4E15-B498-0CD93C719838 @default.
- Q67129299 P4844 Q67129299-964A6185-F7F5-446B-A46C-D7CAFF3B7F4D @default.
- Q67129299 P580 Q67129299-0EA0DCE1-11C2-48E2-BB0B-A34CFE13EB20 @default.
- Q67129299 P582 Q67129299-ACAEAEDC-CCD2-42EF-B368-6FBA91B59DE7 @default.
- Q67129299 P8363 Q67129299-9EBE9532-3470-4E06-8602-1CA8CEE1EFBA @default.
- Q67129299 P859 Q67129299-61668B8C-B1D7-4B26-A498-62AD6177126C @default.
- Q67129299 P1050 Q29496 @default.
- Q67129299 P1132 "+186" @default.
- Q67129299 P1476 "Costs and Outcome Among Patients With Chronic Myelogenous Leukemia (CML) Receiving Dasatinib or Nilotinib as First or Second Line Therapy in a Commercial and Medicare Population" @default.
- Q67129299 P17 Q30 @default.
- Q67129299 P2899 "+18" @default.
- Q67129299 P3098 "NCT02363868" @default.
- Q67129299 P31 Q30612 @default.
- Q67129299 P4844 Q419940 @default.
- Q67129299 P580 "2014-02-01T00:00:00Z" @default.
- Q67129299 P582 "2014-11-01T00:00:00Z" @default.
- Q67129299 P8363 Q818574 @default.
- Q67129299 P859 Q266423 @default.